SEC Form 4 · accession 0001645627-17-000135
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Oct 31, 2017
Accepted (ET)
Nov 3, 2017 · 6:09 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 31, 2017 | P | 3,000 | $0.066 | A | 24,038,189 | D | |
| Common Stock | Oct 31, 2017 | P | 2,000 | $0.066 | A | 24,040,189 | D | |
| Common Stock | Nov 1, 2017 | P | 3,000 | $0.066 | A | 24,043,189 | D | |
| Common Stock | Nov 1, 2017 | P | 2,000 | $0.065 | A | 24,045,189 | D | |
| Common Stock | Nov 1, 2017 | P | 3,000 | $0.064 | A | 24,048,189 | D | |
| Common Stock | Nov 1, 2017 | P | 3,000 | $0.064 | A | 24,051,189 | D | |
| Common Stock | Nov 1, 2017 | P | 3,000 | $0.0639 | A | 24,054,189 | D | |
| Common Stock | Nov 2, 2017 | P | 3,000 | $0.0644 | A | 24,057,189 | D | |
| Common Stock | Nov 2, 2017 | P | 3,000 | $0.064 | A | 24,060,189 | D | |
| Common Stock | Nov 2, 2017 | P | 2,000 | $0.064 | A | 24,062,189 | D | |
| Common Stock | Nov 2, 2017 | P | 1,000 | $0.064 | A | 24,063,189 | D | |
| Common Stock | Nov 2, 2017 | P | 2,000 | $0.0639 | A | 24,065,189 | D | |
| Common Stock | Nov 2, 2017 | P | 2,000 | $0.062 | A | 24,067,189 | D | |
| Common Stock | Nov 2, 2017 | P | 3,000 | $0.062 | A | 24,070,189 | D | |
| Common Stock | Nov 2, 2017 | P | 3,000 | $0.063 | A | 24,073,189 | D | |
| Common Stock | Nov 2, 2017 | P | 3,000 | $0.063 | A | 24,076,189 | D | |
| Common Stock | Nov 2, 2017 | P | 2,000 | $0.0639 | A | 24,078,189 | D | |
| Common Stock | Nov 2, 2017 | P | 3,000 | $0.0638 | A | 24,081,189 | D |
Table II — derivative securities
No Table II lines on this filing.